Payer & formulary research
national and regional payers, formulary committee members, hospital procurement, across 56+ countries
For Market Access, HEOR & Pricing teams
Evidence for the people who decide what gets paid for.
Our network spans the whole decision chain — prescriber, formulary decision-maker, and buyer — so one study can cover all three.
What we run for you
Pricing & reimbursement studies
willingness-to-pay, price-sensitivity, and access-scenario research
Value-message testing
with the payers and access stakeholders who will actually hear them
Geographic variation studies
where practice, funding, and access genuinely differ by market, quantified
From the field
Two studies, as they ran.
From the field
The POC HbA1c Testing Market Across EU5 and APAC: HCPs, Payers, and Manufacturers in One Study
In-depth discussions50 · EU5, China, Japan, Korea, India8 weeks
HCPs, payers and manufacturers in one study: test volumes, purchase pricing, funding, brand shares and the policy outlook.
Read the full story →From the field
What Will Brazil Pay? Payer Interviews on Pricing and Reimbursement Across Four Indications
Payer in-depth interviewsBrazil · 4 indicationsUnder 2 weeks
Brazilian payers on likely pricing under CMED evaluation, reimbursement barriers and the pathway to private-insurance coverage.
Read the full story →Frequently asked, honestly answered.
Can you reach actual formulary decision-makers, not proxies?+
Yes — payers, formulary committee members, hospital procurement, and pharmacy leadership are verified stakeholder types within the network, recruited to named criteria you approve.
Multi-country in one design?+
Standard — one design, in-market and in-language execution, one consolidated deliverable.